BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 742555)

  • 1. Urinary kallikrein excretion and plasma DBH activity in hypertension.
    Greco AV; Porcelli G; Magalhaes JF; Altomonte L
    Agents Actions; 1978 Dec; 8(6):572-5. PubMed ID: 742555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The evaluation of plasma dopamine beta-hydroxylase activity in essential and secondary hypertension.
    Iseki F; Kuchii M; Nishio I; Masuyama Y
    Jpn Heart J; 1979 May; 20(3):307-20. PubMed ID: 572440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma dopamine beta-hydroxylase: a possible aid in the study and evaluation of hypertension.
    Schanberg SM; Stone RA; Kirshner N; Gunnells JC; Robinson RR
    Science; 1974 Feb; 183(4124):523-5. PubMed ID: 4809562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopamine beta-hydroxylase and plasma renin activity in patients with low-, normal-, and high-renin essential hypertension.
    Lawton WJ; Fitz A; Grant C; Witte DL
    Circulation; 1979 May; 59(5):1063-9. PubMed ID: 428086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The meaning of dopamine beta-hydroxylase in essential hypertension.
    Alexandre JM; London GM; Chevillard C; Lemaire P; Safar ME; Weiss Y
    Clin Sci Mol Med; 1975 Dec; 49(6):573-9. PubMed ID: 1204288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary kallikrein excretion and sodium metabolism in hypertensive patients.
    Seino M; Abe K; Otsuka Y; Saito T; Irokawa N
    Tohoku J Exp Med; 1975 Aug; 116(4):359-367. PubMed ID: 1188919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopamine-beta-hydroxylase. An index of adrenergic function in hypertensive patients.
    Stone RA
    West J Med; 1975 Aug; 123(2):108-114. PubMed ID: 1179715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebrospinal fluid and plasma dopamine-beta-hydroxylase activity in human hypertension.
    Cubeddu LX; Davila J; Zschaeck D; Barbella YR; Ordaz P; Dominguez J
    Hypertension; 1981; 3(4):448-55. PubMed ID: 7309207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on the role of sympathetic nervous system in the mechanism of essential hypertension.
    Miyahara M; Iimura O; Shoji T; Okada T
    Jpn Circ J; 1977 Mar; 41(3):228-36. PubMed ID: 870720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma dopamine-beta-hydroxylase activity and blood pressure variability in hypertensive man.
    Levy SB; Frigon RF; Stone RA
    Clin Endocrinol (Oxf); 1979; 11(2):187-99. PubMed ID: 487618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary kallikrein activity is not altered in human essential hypertension.
    Simonetti BM; Pierucci A; Taggi F; Morabito S; Vastano S; Marchetti S; Putini RL; Stirati G; Cinotti GA
    Uremia Invest; 1985-1986; 9(2):189-93. PubMed ID: 3915922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Selected components of the kallikrein-kinin system and of the renin-angiotensin-aldosterone system in offspring of parents with hypertension].
    Marzecka J
    Ann Acad Med Stetin; 1996; 42():123-38. PubMed ID: 9199117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of correlation of plasma norepinephrine and dopamine-beta-hydroxylase in hypertensive and normotensive subjects.
    Lake CR; Ziegler MG; Coleman M; Kopin IJ
    Circ Res; 1977 Dec; 41(6):865-9. PubMed ID: 923037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary kallikrein in normal renin essential hypertension.
    Lawton WJ; Fitz AE
    Circulation; 1977 Nov; 56(5):856-9. PubMed ID: 912848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma and tumor dopamine-beta-hydroxylase activity in patients with familial pheochromocytomas.
    Feldman JM; Blalock JA; Farrell RE; Wells SA
    Metabolism; 1978 Dec; 27(12):1797-802. PubMed ID: 723634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of aging on urinary kallikrein excretion in normotensive subjects and in patients with essential hypertension.
    Naka T; Ogihara T; Hata T; Maruyama A; Mikami H; Nakamaru M; Gotoh S; Masuo K; Ohde H; Iwanaga K; Kumahara Y
    J Clin Endocrinol Metab; 1981 May; 52(5):1023-6. PubMed ID: 6908897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary kallikrein excretion and plasma renin activity in patients with essential hypertension and primary aldosteronism.
    Lechi A; Covi G; Lechi C; Corgnati A; Arosio E; Zatti M; Scuro LA
    Clin Sci Mol Med; 1978 Jul; 55(1):51-5. PubMed ID: 668267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal kallikrein-kinin system and prostaglandin in hypertension: their relation to renin-angiotensin-aldosterone system.
    Abe K; Yasujima M; Chiba S; Sato M; Irokawa N; Imai Y; Yoshinaga K
    Adv Exp Med Biol; 1979; 120B():487-501. PubMed ID: 517244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between urinary kallikrein excretion and plasma atrial natriuretic factor in essential hypertensives.
    Dessì-Fulgheri P; Di Noto G; Palermo R; Catalini R; Russo P; Rappelli A
    J Hypertens Suppl; 1989 Dec; 7(6):S232-3. PubMed ID: 2534406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopamine-beta-hydroxylase and plasma renin activity in twenty hypertensive subjects.
    Aberg H; Hedstrand H; Wetterberg L; Ross SB
    Ups J Med Sci; 1975; 80(1):24-6. PubMed ID: 1145901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.